We are live on ! Find out more
AVNS icon

Avanos Medical

287 hedge funds and large institutions have $1.18B invested in Avanos Medical in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 89 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

13,850% more call options, than puts

Call options by funds: $279K | Put options by funds: $2K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.39% less ownership

Funds ownership: 92.93%91.54% (-1.4%)

4% less funds holding

Funds holding: 299287 (-12)

13% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 40

13% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 89

17% less capital invested

Capital invested by funds: $1.42B → $1.18B (-$237M)

Holders
287
Holders Change
-12
Holders Change %
-4.01%
% of All Funds
4.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
77
Reduced
89
Closed
40
Calls
$279K
Puts
$2K
Net Calls
+$277K
Net Calls Change
-$396K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$208M -$86.5K -3,012 -0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$147M +$1.21M +42,268 +0.8%
RC
3
RGM Capital
Florida
$81.4M +$611K +21,264 +0.7%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$72.2M +$7.87M +273,823 +12%
PIM
5
Paradice Investment Management
Colorado
$63.2M -$4.31M -150,095 -6%
State Street
6
State Street
Massachusetts
$55M -$249K -8,653 -0.4%
Goldman Sachs
7
Goldman Sachs
New York
$51.4M -$3.44M -119,844 -6%
Macquarie Group
8
Macquarie Group
Australia
$41.6M +$249K +8,657 +0.6%
WHG
9
Westwood Holdings Group
Texas
$29.2M -$252K -8,771 -0.8%
Neuberger Berman Group
10
Neuberger Berman Group
New York
$22.6M +$175K +6,103 +0.7%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$22.5M -$465K -16,196 -2%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$21.3M -$3.36M -116,815 -13%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$19.9M +$143K +4,964 +0.7%
Northern Trust
14
Northern Trust
Illinois
$18.3M +$904K +31,462 +5%
Charles Schwab
15
Charles Schwab
California
$16.5M +$1.4M +48,842 +9%
N
16
Nuveen
North Carolina
$16.3M +$25.4K +884 +0.1%
TCM
17
Tributary Capital Management
Nebraska
$16M +$1.38M +48,172 +9%
Morgan Stanley
18
Morgan Stanley
New York
$15.1M +$2.66M +92,718 +20%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$14.2M -$89.1K -3,100 -0.6%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$13.9M -$1.32M -46,027 -8%
Norges Bank
21
Norges Bank
Norway
$11.2M -$1.22M -42,299 -9%
HA
22
Heartland Advisors
Wisconsin
$10.8M +$1.33M +46,287 +13%
Ameriprise
23
Ameriprise
Minnesota
$9.85M -$370K -12,877 -3%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$9.68M +$1.87M +65,163 +23%
AIMCA
25
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$9.55M

AVNS Hedge Fund Activity: Q2 2022 in Review

287 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2022, worth a combined $1.18B — down 17% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of AVNS and 35 opened new positions — a net loss of 5 holders — while 89 trimmed existing stakes and 77 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $7.87M. The largest seller was Millennium Management, cutting an estimated $11.3M.

  • 287 institutional investors held Avanos Medical (AVNS) as of Q2 2022, down from 299 in Q1 2022.
  • Funds reported $1.18B of Avanos Medical stock for Q2 2022, down 17% quarter-over-quarter.
  • 35 funds opened new Avanos Medical positions in Q2 2022 and 40 closed out, a net change of -5 holders.
  • The largest Avanos Medical buyer in Q2 2022 was Dimensional Fund Advisors, an estimated $7.87M added.
  • The largest Avanos Medical seller in Q2 2022 was Millennium Management, an estimated $11.3M sold.

Based on aggregated 13F filings for Q2 2022.